Myristic acid selectively augments β-tubulin levels in C2C12 myotubes via diacylglycerol kinase δ.


Journal

FEBS open bio
ISSN: 2211-5463
Titre abrégé: FEBS Open Bio
Pays: England
ID NLM: 101580716

Informations de publication

Date de publication:
10 2022
Historique:
revised: 29 06 2022
received: 17 04 2022
accepted: 19 07 2022
pubmed: 21 7 2022
medline: 5 10 2022
entrez: 20 7 2022
Statut: ppublish

Résumé

Effective amelioration of type II diabetes requires therapies that increase both glucose uptake activity per cell and skeletal muscle mass. Myristic acid (14:0) increases diacylglycerol kinase (DGK) δ protein levels and enhances glucose uptake in myotubes in a DGKδ-dependent manner. However, it is still unclear whether myristic acid treatment affects skeletal muscle mass. In this study, we found that myristic acid treatment increased the protein level of β-tubulin, which constitutes microtubules and is closely related to muscle mass, in C2C12 myotubes but not in the proliferation stage in C2C12 myoblasts. However, lauric (12:0), palmitic (16:0) and oleic (18:1) acids failed to affect DGKδ and β-tubulin protein levels in C2C12 myotubes. Moreover, knockdown of DGKδ by siRNA significantly inhibited the increased protein level of β-tubulin in the presence of myristic acid, suggesting that the increase in β-tubulin protein by myristic acid depends on DGKδ. These results indicate that myristic acid selectively affects β-tubulin protein levels in C2C12 myotubes via DGKδ, suggesting that this fatty acid improves skeletal muscle mass in addition to increasing glucose uptake activity per cell.

Identifiants

pubmed: 35856166
doi: 10.1002/2211-5463.13466
pmc: PMC9527581
doi:

Substances chimiques

RNA, Small Interfering 0
Tubulin 0
Myristic Acid 0I3V7S25AW
Diacylglycerol Kinase EC 2.7.1.107
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1788-1796

Informations de copyright

© 2022 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Références

Biochimie. 2018 Aug;151:45-53
pubmed: 29859210
J Biol Chem. 2014 Sep 19;289(38):26607-26617
pubmed: 25112873
Mol Cell Biol. 1999 Jul;19(7):5203-17
pubmed: 10373569
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Feb;1863(2):143-151
pubmed: 29155055
J Biol Chem. 2007 Nov 2;282(44):31835-43
pubmed: 17675299
Nat Cell Biol. 2001 Nov;3(11):1009-13
pubmed: 11715022
Nature. 1993 Aug 5;364(6437):532-5
pubmed: 8393146
Lipids. 2016 Aug;51(8):897-903
pubmed: 27206979
Diabetes Res Clin Pract. 2022 Jan;183:109119
pubmed: 34879977
Life Sci. 2009 Mar 27;84(13-14):415-20
pubmed: 19302823
Diabetologia. 2017 Oct;60(10):2076-2083
pubmed: 28707095
Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1168-78
pubmed: 15687108
Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):492-8
pubmed: 16752430
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jul;1864(7):1031-1038
pubmed: 30980919
Curr Biol. 2007 Aug 7;17(15):1318-25
pubmed: 17658256
Elife. 2015 Apr 21;4:e05697
pubmed: 25898002
Biochim Biophys Acta. 2007 Jul;1771(7):793-806
pubmed: 17512245
Cell. 2008 Feb 8;132(3):375-86
pubmed: 18267070
Diabetes Care. 1990 Mar;13(3):228-43
pubmed: 2407478
Mol Cell Biol. 1994 Aug;14(8):5259-67
pubmed: 8035804
Chem Rev. 2011 Oct 12;111(10):6186-208
pubmed: 21800853
FEBS J. 2013 Sep;280(17):3991-4003
pubmed: 23419170
Nat Cell Biol. 2001 Nov;3(11):1014-9
pubmed: 11715023
Nutrients. 2019 Sep 03;11(9):
pubmed: 31484459
Lancet Diabetes Endocrinol. 2014 Oct;2(10):819-29
pubmed: 24731660
Nature. 1993 Aug 5;364(6437):501-6
pubmed: 8393145
Lipids. 2014 Jul;49(7):633-40
pubmed: 24852321
J Cell Sci. 2009 May 1;122(Pt 9):1401-9
pubmed: 19366726
J Biochem. 2012 Nov;152(5):397-406
pubmed: 22984004
Cell Struct Funct. 1991 Jun;16(3):251-61
pubmed: 1913855
Adv Biol Regul. 2018 Jan;67:101-108
pubmed: 28918129
Biochem J. 2008 Jan 1;409(1):1-18
pubmed: 18062770
J Biol Chem. 1996 Apr 5;271(14):8394-401
pubmed: 8626538
Front Physiol. 2020 Jun 03;11:563
pubmed: 32581844

Auteurs

Hiromichi Sakai (H)

Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Organization for Research and Academic Information, Shimane University, Izumo, Japan.

Ken-Ichi Matsumoto (KI)

Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Organization for Research and Academic Information, Shimane University, Izumo, Japan.

Takeshi Urano (T)

Department of Biochemistry, Shimane University School of Medicine, Izumo, Japan.

Fumio Sakane (F)

Department of Chemistry, Graduate School of Science, Chiba University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH